Please login to the form below

Not currently logged in
Email:
Password:

Annexa

This page shows the latest Annexa news and features for those working in and with pharma, biotech and healthcare.

Novel anticoagulant antidotes prove their worth

Novel anticoagulant antidotes prove their worth

Portola Pharmaceuticals and Bristol-Myers Squibb (BMS) has reported phase III data on its Factor Xa inhibitor antidote Annexa (andexanet alfa), showing it can effectively reverse the anticoagulant effects of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics